Promises
3 promises
Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →
Tata Consumer Products — Q4 FY25
Tata Consumer Products reported a strong Q4 FY25 with consolidated revenue of INR 4,608 crore, up 17% YoY (12% organic).
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Tata Consumer Products reported a strong Q4 FY25 with consolidated revenue of INR 4,608 crore, up 17% YoY (12% organic). India branded business UVG grew 6%, with tea volumes up 2% and salt volumes up 5%. EBITDA margin contracted 250 bps to 13.6% due to tea cost inflation, partially offset by price increases (46% recovery in Q4). PAT surged 64% to INR 349 crore, aided by one-off credits. Growth businesses (Sampann, Soulful, etc.) now account for 28% of India revenue, growing 24%. International EBITDA margins expanded 190 bps for the full year. Management expects tea costs to soften with a normal crop, targeting EBITDA margin recovery to ~16% by Q2/Q3 FY26. Key risk: sustained tea cost inflation or adverse crop conditions could delay margin recovery.
टाटा कंज्यूमर प्रोडक्ट्स ने वित्त वर्ष 2025 की चौथी तिमाही में मजबूत प्रदर्शन किया। कंपनी की कुल आय 4,608 करोड़ रुपये रही, जो पिछले साल से 17% ज्यादा है। भारत में ब्रांडेड कारोबार की बिक्री 6% बढ़ी, चाय की बिक्री 2% और नमक की 5% बढ़ी। चाय की लागत बढ़ने से मुनाफा मार्जिन 13.6% रह गया, लेकिन कीमतें बढ़ाकर इसका कुछ असर कम किया गया। कंपनी का शुद्ध लाभ 349 करोड़ रुपये रहा, जो 64% ज्यादा है। नए कारोबार (जैसे संपन्न, सोलफुल) अब भारत की आय का 28% हिस्सा हैं। कंपनी को उम्मीद है कि चाय की लागत कम होगी और अगले साल की दूसरी-तीसरी तिमाही तक मुनाफा मार्जिन 16% तक पहुंच जाएगा। लेकिन अगर चाय की लागत बढ़ती रही तो यह लक्ष्य पूरा होने में देरी हो सकती है।
Promises0 met · 3 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Sustained tea cost inflation
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
India Branded UVG
6%
+6pp YoY
Underlying volume growth for India branded business in Q4 FY25, a new disclosure metric.
Tea Volume Growth
2%
+2pp YoY
Tea volumes turned positive after soft H1, driven by strong H2 execution.
Salt Volume Growth
5%
+5pp YoY
Salt volumes grew decently despite price increases, sustaining mid-single-digit trend.
E-commerce Growth
66%
+66pp YoY
E-commerce channel grew 66% in Q4, now ~14% of total business (half quick commerce).
What Changed vs Last Quarter
NEW
EBITDA margin recovery to ~16% by Q2/Q3 FY26
Management expects EBITDA margins to normalize to ~16% as tea costs soften with a normal crop, with recovery starting by end of Q2 FY26.
NEW
Growth businesses to grow at 30% CAGR
Sampann, Soulful, and other growth businesses are expected to continue growing at ~30% annually, maintaining their 30% revenue contribution target.
NEW
Capex to remain at current year levels as % of revenue
Capex for FY26 will be similar to FY25 levels, with no significant new investments; Vietnam capex continues into H1 FY26.
UPDATED
Capital Foods and Organic India to grow at 30%
Management remains confident of 30% revenue growth for Capital Foods and Organic India in FY26, with margins in line with business case.
DROPPED
Tea margin pressure to ease from Q4 FY25
Management expects Q3 to be the peak of tea margin pressure, with gradual improvement as price hikes flow through and new crop arrives in Q1 FY26.
DROPPED
Growth businesses to contribute 30% of portfolio
Target for growth businesses (Sampann, Soulfull, etc.) to grow at 30% and contribute 30% of portfolio; currently at 27% contribution with 89% growth.
DROPPED
Pharma channel expansion for Organic India
Piloted in 10 cities, pharma channel to expand to 40 cities next year, driving significant uplift for Organic India.
NEW RISK
Sustained tea cost inflation
Tea prices remain ~15% higher YoY; if crop normalizes slower than expected, margin recovery could be delayed beyond Q2 FY26.
NEW RISK
Down-trading in tea portfolio
Analyst noted that unlike previous cycles, branded players are not gaining market share; management attributed this to down-trading to cheaper options, which could persist if inflation continues.
NEW RISK
U.S. tariff impact on international business
Potential U.S. tariffs could affect coffee and tea exports; management downplayed the impact but acknowledged uncertainty, especially for Organic India exports.
NEW RISK
Recessionary risk in U.K. and U.S. markets
Analyst raised concern about revenue momentum in U.K./U.S. due to recession risks; management expressed confidence in U.K. but was less certain on U.S.
RISK GONE
Sustained high tea prices
Tea input costs remain elevated with only 40% passed through; if prices don't ease or further hikes aren't taken, margins could remain under pressure for two more quarters.
RISK GONE
Coffee price volatility impacting non-branded demand
Coffee prices at 50-year highs; management is cautious on inventory and notes potential demand destruction if prices persist.
RISK GONE
Competitive intensity in RTD business
Analyst raised concern about new entrants and pricing aggression; management acknowledged matching deeper retail margins, impacting revenue growth.
RISK GONE
Urban slowdown impact on premium portfolio
Analyst questioned volume growth in Salt and Sampann given urban slowdown; management noted urban growth is low single digits excluding modern trade and e-commerce.
🤫 Topics management stopped discussing
Mentioned in Q1 FY25, Q3 FY24, Q4 FY24
Management reiterated commitment to grow the growth businesses (including acquisitions) from 20% to 30% of the India portfolio, with these businesses growing at 30% CAGR.
Mentioned in Q1 FY24, Q2 FY24, Q4 FY24
Management disputes Nielsen data showing 7% industry growth, claiming they haven't lost share. If competitive data confirms loss, tea volumes could remain soft.
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management remains confident of delivering INR 900-1,000 crore for NourishCo in FY24, despite Q3 being seasonally weak.
Mentioned in Q3 FY25, Q4 FY24
Coffee prices at 50-year highs; management is cautious on inventory and notes potential demand destruction if prices persist.
Mentioned in Q2 FY24, Q2 FY25
The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.
Fast read
Guidance and risk preview
Management expects EBITDA margins to normalize to ~16% as tea costs soften with a normal crop, with recovery starting by end of Q2 FY26.
Tea prices remain ~15% higher YoY; if crop normalizes slower than expected, margin recovery could be delayed beyond Q2 FY26.
View Risks →